Começar
Pfizer
Viés de alta

Q3 Trade Pfizer

Por OssianH
Q3 results for Pfizer were solid, with adjusted earnings and revenue surpassing expectations. The current drop in share price seems excessive and may be driven by liquidity concerns rather than underlying performance issues. The significant decline in expected sales for COVID products is concerning, but overall, the fundamentals appear stable. This drop could present a buying opportunity if it’s mainly a liquidity grab

Comentário
28.8 needs some type of confirmation, whether it's a retest or very strong orders. This level is crucial for assessing the market's next move
Comentário
Small entry now 28.250
Comentário
locked in 50% with a 1.3% gain x40 levrage. Holding rest BOS
Beyond Technical AnalysisChart PatternsFundamental Analysis
OssianH

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.